Eosinophils in Cancer: Favourable or Unfavourable?

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|7|650-666

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.7, 2016-02, pp. : 650-666

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A regimen of trastuzumab, paclitaxel, carboplatin and gemcitabine has favourable efficacy in advanced, HER2-positive urothelial cancer

By  

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Sulfonylureas show unfavourable risk profiles

By  

Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Bazedoxifene endometrial effects favourable

By  

Inpharma, Vol. 1, Iss. 1497, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Favourable findings with fluticasone furoate

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

DES show "unfavourable" cost effectiveness results

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 581, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite